Delivery Order SPE2DR25D2002-SPE2DR26FBRZ1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Durolane 60 mg/3 ml syringes with a firm fixed price ceiling value of $13,921.45 and an ultimate completion date of November 18, 2025. This delivery order was competitively awarded with no set-aside designation and represents a specific fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $11,506.50 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Durolane 60 mg/3 ml syringes at a ceiling value of $1,275.20. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's location...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.54 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes (3 mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,075.01 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This competitively awarded, firm fixed price contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,736.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,902.13. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBRZ1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $3,329.64 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of November 18, 2025. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract running through December 2026 that serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC enables AmerisourceBergen to deliver specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other medical commodities across multiple therapeutic domains to authorized customers including the Defense Health Agency and U.S. Coast Guard. The firm's consistent performance on competitively awarded delivery orders and its established position as a pharmaceutical prime vendor demonstrates its capability to meet DLA's medical supply requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 11/17/25 |